TAK-085 (omega-3-acid ethyl esters)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-085 (omega-3-acid ethyl esters), covering 2019-05-06 to 2019-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation [Phase 4]